ArticleBiomedical optics express2020
Optimal breast cancer diagnostic strategy using combined ultrasound and diffuse optical tomography.
Article in Biomedical optics express, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- AI-assisted diffuse correlation tomography for identifying breast cancer.Journal of biomedical optics · 2025Article
- Diffuse correlation tomography: a technique to characterize tissue blood flow abnormalities in benign and malignant breast lesions.Biomedical optics express · 2024Article
- Monitoring of neoadjuvant chemotherapy through time domain diffuse optics: breast tissue composition changes and collagen discriminative potential.Biomedical optics express · 2024Article
- Real-time breast lesion classification combining diffuse optical tomography frequency domain data and BI-RADS assessment.Journal of biophotonics · 2024Article
- Self-Guided Algorithm for Fast Image Reconstruction in Photo-Magnetic Imaging: Artificial Intelligence-Assisted Approach.Bioengineering (Basel, Switzerland) · 2024Article
- Automated pipeline for breast cancer diagnosis using US assisted diffuse optical tomography.Biomedical optics express · 2023Article
- Two-stage classification strategy for breast cancer diagnosis using ultrasound-guided diffuse optical tomography and deep learning.Journal of biomedical optics · 2023Article
- Fusion deep learning approach combining diffuse optical tomography and ultrasound for improving breast cancer classification.Biomedical optics express · 2023Article
- Machine Learning Diffuse Optical Tomography Using Extreme Gradient Boosting and Genetic Programming.Bioengineering (Basel, Switzerland) · 2023Article
- A Clinical Study to Assess Diffuse Reflectance Spectroscopy with an Auto-Calibrated, Pressure-Sensing Optical Probe in Head and Neck Cancer.Current oncology (Toronto, Ont.) · 2023Article
- Estimation of the Differential Pathlength Factor for Human Skin Using Monte Carlo Simulations.Diagnostics (Basel, Switzerland) · 2023Article
- Differentiating non-lactating mastitis and malignant breast tumors by deep-learning based AI automatic classification system: A preliminary study.Frontiers in oncology · 2022Article
- [Study on the inverse problem of diffuse optical tomography based on improved stacked auto-encoder].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Ultrasound (US)-guided near-infrared diffuse optical tomography (DOT) has demonstrated great potential as an adjunct breast cancer diagnosis tool to US imaging alone, especially in reducing unnecessary benign biopsies. However, DOT data processing and image reconstruction speeds remain slow compared to the real-time speed of US. Real-time or near real-time diagnosis with DOT is an important step toward the clinical translation of US-guided DOT. Here, to address this important need, we present a two-stage diagnostic strategy that is both computationally efficient and accurate. In the first stage, benign lesions are identified in near real-time by use of a random forest classifier acting on the DOT measurements and the radiologists' US diagnostic scores. Any lesions that cannot be reliably classified by the random forest classifier will be passed on to the second stage which begins with image reconstruction. Functional information from the reconstructed hemoglobin concentrations is employed by a Support Vector Machine (SVM) classifier for diagnosis at the end of the second stage. This two-step classification approach which combines both perturbation data and functional features, results in improved classification, as denoted by the receiver operating characteristic (ROC) curve. Using this two-step approach, the area under the ROC curve (AUC) is 0.937 ± 0.009, with a sensitivity of 91.4% and specificity of 85.7%. In comparison, using functional features and US score yields an AUC of 0.892 ± 0.027, with a sensitivity of 90.2% and specificity of 74.5%. Most notably, the specificity is increased by more than 10% due to the implementation of the random forest classifier.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.